Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
UBS
Accenture
US Army
Boehringer Ingelheim
Moodys
Fish and Richardson
Queensland Health

Generated: May 27, 2018

DrugPatentWatch Database Preview

TAMBOCOR Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Tambocor, and what generic alternatives are available?

Tambocor is a drug marketed by Cnty Line Pharms and is included in one NDA.

The generic ingredient in TAMBOCOR is flecainide acetate. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the flecainide acetate profile page.
Drug patent expirations by year for TAMBOCOR
Pharmacology for TAMBOCOR
Drug ClassAntiarrhythmic
Medical Subject Heading (MeSH) Categories for TAMBOCOR
Synonyms for TAMBOCOR
(-)-Flecainide
(+-)-Flecainide
(+)-Flecainide
(+/-)-Flecainide solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
143F554
2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)-benzamide
2,5-bis(2,2,2-trifluoroethoxy)-N-(2-piperidylmethyl)benzamide
54143-55-4
54143-56-5 (monoacetate)
99495-87-1
AB00384356-13
AB00513907
AC-16019
AC1L1FQZ
ACM127413314
AK116465
AKOS015962192
Almarytm (TN)
AN-40629
API0002709
Apocard (TN)
AX8130409
BCBcMAP01_000189
BDBM50131434
Benzamide, N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-
Benzenesulfonamide, 2-methoxy-N-(1,2,3,4-tetrahydro-3-methyl-2-oxo-6-quinazolinyl)-
Bio1_000375
Bio1_000864
Bio1_001353
Bio2_000037
Bio2_000517
BPBio1_000760
BRD-A09472452-001-02-8
BRD-A09472452-015-03-6
BSPBio_000690
BSPBio_001317
C-21963
C07001
C17H20F6N2O3
CAS-54143-55-4
CC-28436
CCG-204636
CCRIS 313
CHEBI:75984
CHEMBL652
D03DAP
D07962
D0N5FI
DB01195
DJBNUMBKLMJRSA-UHFFFAOYSA-N
DR002496
DSSTox_CID_3054
DSSTox_GSID_23054
DSSTox_RID_76854
DTXSID8023054
Ecrinal (TN)
EN300-144572
Flecaine
Flecainida
Flecainida [INN-Spanish]
flecainide
Flecainide (INN)
Flecainide [INN:BAN]
Flecainidum
Flecainidum [INN-Latin]
FT-0630666
GTPL2560
HE304978
HE350452
HMS1791B19
HMS1989B19
HMS2089E17
Ic Flecainide
IDI1_033787
KB-258301
KBio2_000037
KBio2_002605
KBio2_005173
KBio3_000073
KBio3_000074
KBioGR_000037
KBioSS_000037
Lopac0_000546
LS-27388
MCULE-3327347453
N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide #
N-(2-Piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide
N-(piperidin-2-ylmethyl)-2,5-bis[(2,2,2-trifluoroethyl)oxy]benzamide
N-[(piperidin-2-yl)methyl]-2,5-bis(2,2,2-trifluoroethoxy)benzamide
N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide
N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide (Flecainide)
N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide(Flecainide)
N-Piperidin-2-ylmethyl-2,5-bis-(2,2,2-trifluoro-ethoxy)-benzamide(Flecanide)
NCGC00015443-04
NCGC00015443-05
NCGC00015443-06
NCGC00015443-07
NCGC00015443-08
NCGC00015443-10
NCGC00015443-11
NCGC00015443-12
NCGC00015443-13
NCGC00015443-14
NCGC00015443-15
NCGC00015443-17
NCGC00025175-03
NCGC00025175-04
NCGC00025175-05
NCGC00025175-06
NSC-719273
NSC719273
Prestwick0_000735
Prestwick1_000735
Prestwick2_000735
Prestwick3_000735
SCHEMBL14970
SMP1_000074
SPBio_002629
Tambocor (TN)
TL80090300
Tox21_110151
Tox21_110151_1

US Patents and Regulatory Information for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TAMBOCOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Army
Cantor Fitzgerald
Cipla
Farmers Insurance
Citi
Chinese Patent Office
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.